PURETECH HEALTH : Bristol-Myers Squibb and PureTech’s Vedanta Biosciences Announce New Immuno-Oncology Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers

Press/Media

Period	10 Dec 2018

Media coverage

Title	PURETECH HEALTH : Bristol-Myers Squibb and PureTech’s Vedanta Biosciences Announce New Immuno-Oncology Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	10/12/18
URL	https://www.marketscreener.com/PURETECH-HEALTH-PLC-22619613/news/Puretech-Health-Bristol-Myers-Squibb-and-PureTech-rsquo-s-Vedanta-Biosciences-Announce-New-Immuno-27729522/
Persons	Jeremiah Faith